Optically Active Mixed Unsymmetric Imine Platinum(II) Complexes
4.20 (s, 4 H, CH2CO2Me), 8.06 and 8.19 (two s, br, 2 H, NH) ppm.
13C{1H} NMR: δ = 11.5, 19.0, 20.1 (Me), 17.9 and 22.4 (=CMe2),
1.43–1.54 (m, 1 H), 1.64–2.13 (m, 4 H), 2.59–2.65 (m, 1 H), 3.79
(s, 3 H, MeO), 4.17 and 4.21 (two s, 2 H, CH2), 8.06 (br. s, 1 H,
27.5, 32.8, 35.7 (CH2), 39.9 and 40.2 (CH2CO2Me), 44.0 (CH), 49.7 NH) ppm. 13C{1H} NMR: δ = 11.5, 19.0, 20.1 (Me), 27.5, 32.8,
(CMe), 53.3 (CMe2), 54.4 (MeO), 166.2 (CO2Me), 167.1 (=CMe2),
167.7 and 168.1 [C(O)=N], 179.9 [(O)N=CCH2] ppm. 195Pt NMR:
δ = –2058 (J = 886 Hz) ppm. FAB+-MS: m/z = 704 [M]+.
35.7 (CH2), 40.1 (CH2CO2Me), 44.0 (CH), 49.6 (CMe), 53.3
(CMe2), 54.4 (MeO), 167.2 (CO2Me), 168.0 [C(O)=N], 179.8 [(O)-
N=CCH2] ppm. 195Pt NMR: δ = –2060 (J = 846 Hz) ppm. FAB+-
C21H34Cl2N4O6Pt (704.50): calcd. C 35.80, H 4.86, N 7.95; found MS: m/z = 798 [M]+. C28H44Cl2N4O6Pt (798.66): calcd. C 42.11, H
C 35.75, H 4.80, N 7.86.
5.55, N 7.02; found C 42.54, H 5.77, N 6.95.
trans-(R*)-[PtCl2{NH=C(CH2CO2Me)ON=C(C9H16)}{NH=C-
trans-[PtCl2{NH=C(Ph)ON=C(C9H16)}2] (7b): Method (i)
(CH2CO2Me)ON=C(C4H8)}] (6b): Method (i) (33.3 mg, 49 % (43.5 mg, 50% yield), method (ii) (47.8 mg, 55% yield). IR: ν =
˜
1
yield), method (ii) (37.3 mg, 55% yield). [α]2D0 = –36.8 (c = 0.49 in
3463 (NH), 1637 (C=N) cm–1. H NMR: δ = 0.82, 0.95, and 1.11
CHCl ). IR: ν = 3432 (NH), 1749 (CO Me), 1652 (C=N) cm–1. 1H (three s, 3 H each, Me groups), 1.18–1.27 (m, 1 H), 1.49–1.61 (m,
˜
3
2
NMR: δ = 0.81, 0.95, and 1.07 (three s, 3 H each, Me groups),
1.26–2.55 (m, 15 H) [CH2, CH, and =C(C4H8)], 3.80 (s, 6 H, MeO),
4.19 and 4.20 (two s, 2 H each, CH2CO2Me), 8.07 and 8.14 (two s,
br, 2 H, NH) ppm. 13C{1H} NMR: δ = 11.5, 19.0, 20.1 (Me), 25.1,
25.7, 30.4, 32.1 [=C(C4H8)], 27.5, 32.9, 35.7 (CH2), 40.0 and 40.2
1 H), 1.76–1.96 (m, 3 H), 2.14–2.20 (m, 1 H), 2.64–2.71 (m, 1 H),
7.46–7.63 (m, 3 H), 8.24 (br. s, 1 H, NH), 8.64 (d, JHH = 7.2 Hz,
2 H) ppm. 13C{1H} NMR: δ = 10.9, 18.3, 19.4 (Me), 26.8, 32.2,
35.1 (CH2), 43.3 (CH), 48.9 (CMe), 53.6 (CMe2), 127.9, 129.2,
129.4, 132.1 (Caromatic), 167.2 [C(O)=N], 178.4 [(O)N=CCH2] ppm.
(CH2CO2Me), 44.0 (CH), 49.6 (CMe), 53.4 (CMe2), 54.4 (MeO), 195Pt NMR: δ = –1947 (J = 750 Hz) ppm. FAB+-MS: m/z = 806
167.2 (CO2Me), 167.9 [N=C(C4H8)], 168.1 and 177.8 [C(O)=N],
[M]+. C34H44Cl2N4O2Pt (806.72): calcd. C 50.62, H 5.50, N 6.95;
179.9 [(O)N=CCH2] ppm. 195Pt NMR: δ = –2059 (J = 874 Hz) found C 50.94, H 5.25, N 6.56.
ppm. FAB+-MS: m/z = 730 [M]+. C23H36Cl2N4O6Pt (730.54): calcd.
Liberation of the Iminoacylated Oxime 8: The ligand dppe (39.5 mg,
C 37.81, H 4.97, N 7.67; found C 37.90, H 4.80, N 7.77.
0.099 mmol) was added to a solution of trans-[PtCl2{NH=C(R)-
ON=C(C9H16)}2] (7) {R = CH2CO2Me (7a), Ph (7b)} (0.049 mmol)
in CDCl3 (1 mL, 99.8% D), and the mixture was left to stand for
30 min, with the release of a colorless precipitate of [Pt(dppe)2]Cl2.
This solid was removed by filtration, and the filtrate was charac-
terized by NMR and, after being taken to dryness, by IR and FAB-
trans-(R*)-[PtCl2{NH=C(Ph)ON=C(C9H16)}{NH=C(Ph)-
ON=CMe2}] (6c): Method (i) (29.8 mg, 45 % yield), method (ii)
(34.4 mg, 52% yield). [α]2D0 = –8.8 (c = 0.25 in CHCl ). IR: ν =
˜
3
1634 (C=N) cm–1. H NMR: δ = 0.82, 0.96, and 1.12 (three s, 3 H
1
each, Me groups), 1.20–1.28 (m, 2 H), 1.50–1.56 (m, 2 H), 1.86–
1.96 (m, 1 H), 2.07 and 2.08 (two s, 3 H each, =CMe2), 2.57–2.71 MS.
(m, 2 H), 7.46–7.64 (m, 6 H), 8.22 and 8.36 (two s, br, 2 H, NH),
NH=C(CH2CO2Me)ON=C(C9H16) (R*-8a): [α]2D0 = –32.7 (c = 0.40
in CHCl ). IR: ν = 1749 (CO Me), 1611 and 1672 (C=N) cm–1. 1H
8.66 (t, JHH = 8.1 Hz, 4 H) ppm. 13C{1H} NMR: δ = 10.9, 18.3,
19.4 (Me), 17.3 and 21.8 (=CMe2), 26.8, 32.2, 35.2 (CH2), 43.4
(CH), 49.0 (CMe), 53.6 (CMe2), 127.9, 128.1, 129.1, 129.2, 129.4,
132.1, 133.4, and 134.5 (Caromatic), 164.6 (=CMe2), 167.3 and 168.4
[C(O)=N], 179.3 [(O)N=CCH2] ppm. 195Pt NMR: δ = –2177 (J =
876 Hz) ppm. FAB+-MS: m/z = 712 [M]+. C27H34Cl2N4O2Pt
(712.57): calcd. C 45.51, H 4.81, N 7.86; found C 45.72, H 5.01, N
8.21.
˜
3
2
NMR: δ = 0.81, 0.92, and 1.05 (three s, 3 H each, Me groups),
1.21–1.26 (m, 1 H), 1.44–1.47 (m, 1 H), 1.75–1.94 (m, 3 H), 2.10–
2.18 (m, 1 H), 2.59–2.65 (m, 1 H), 3.65 (s, 3 H, MeO), 3.72 and
4.38 (two s, 2 H, CH2), 7.67 (br. s, 1 H, NH) ppm. 13C{1H} NMR:
δ = 10.9, 18.4, 19.4 (Me), 27.0, 32.5, 34.6 (CH2), 43.5 (CH), 48.6
(CMe), 50.2 (MeO), 53.0 (CMe2), 64.3 (CH2CO2Me), 168.8
[C(O)=N], 171.8 (CO2Me), 175.2 [(O)N=CCH2] ppm. FAB+-MS:
m/z = 266 [M]+.
trans-(R*)-[PtCl2{NH=C(Ph)ON=C(C9H16)}{NH=C(Ph)ON=C-
(C4H8)}] (6d): Upon evaporation of the solvent, the initially yellow
solution transformed into a dark oil, with product decomposition,
precluding the possibility of recording reliable characterization
data.
NH=C(Ph)ON=C(C9H16) (R*-8b): [α]2D0 = –15.2 (c = 0.37 in
1
CHCl ). IR: ν = 1650 (C=N) cm–1. H NMR: δ = 0.85, 0.97, and
˜
3
1.14 (three s, 3 H each, Me groups), 1.27–1.34 (m, 1 H), 1.48–1.62
(m, 1 H), 1.77–2.00 (m, 3 H), 2.24–2.30 (m, 1 H), 2.71–2.79 (m, 1
Reaction of trans-[PtCl2(NCR)2] (1) {R = CH2CO2Me (1a), Ph H), 7.30 (d, JHH = 6.0 Hz, 2 H), 7.38–7.48 (m, 2 H), 7.69 (br. s, 1
(1b)} or trans-(R*)-[PtCl2{NH=C(R)ON=C(C9H16)}(NCR)] (4) {R H, NH), 8.01 (d, JHH = 6.0 Hz, 1 H) ppm. 13C{1H} NMR: δ = 11.0,
= CH2CO2Me (4a), Ph (4b)} with (R*)-Camphor Oxime (2)
18.5, 19.5 (Me), 27.1, 32.6, 34.8 (CH2), 43.6 (CH), 48.6 (CMe),
53.0 (CMe2), 127.6, 128.1, 129.1, 131.9 (Caromatic), 162.7 [C(O)=N],
176.0 [(O)N=CCH2] ppm. FAB+-MS: m/z = 270 [M]+.
Reactions of the Mono-Iminoacylated PtII Complexes trans-(R*)-
[PtCl2{NH=C(R)ON=C(C9H16)}(NCR)] (4) {R = CH2CO2Me
(4a), Ph (4b)} with the Diimino Ester NH=C(CH2CO2Me)ON=C-
(C9H16) (R*-8a)
(i) By the Conventional Method: A solution of 1a (50.0 mg,
0.108 mmol), 1b (51.0 mg, 0.108 mmol), 4a (58.7 mg, 0.093 mmol),
or 4b (59.5 mg, 0.093 mmol) in dry CH2Cl2 (3 mL) was added at
room temperature to (R*)-camphor oxime (2) (2 equiv. for 1a–b or
1 equiv. for 4a–b). The mixture was heated with stirring at 40 °C
for 15 or 60 min (for 1a and 4a or 1b and 4b, respectively).
(ii) By Focused Microwave Irradiation: A CH2Cl2 solution of the
reagents in the above amounts was subjected to focused microwave
irradiation at 40 °C for 5 or 20 min (for 1a and 4a or 1b and 4b,
respectively). In both cases, the corresponding symmetric bis-imi-
noacylated products 7 were isolated and purified as indicated
above.
Diimino ester 8a (35.6 mg, 0.134 mmol) was added to a solution of
4a (50.0 mg, 0.079 mmol) or 4b (50.0 mg, 0.078 mmol) in dry
CH2Cl2 at room temperature, and the reaction solution was stirred
for 2 h. The progress of the reaction was monitored by TLC
(CH2Cl2 as eluent). After concentration of the solution in vacuo to
dryness, the crude residue was purified by column chromatography
on silica (CH2Cl2 as eluent) followed by evaporation of the solvent
in vacuo to give the corresponding complexes 9.
trans-[PtCl2{NH=C(CH2CO2Me)ON=C(C9H16)}2] (7a): Method
(i) (41.4 mg, 48% yield), method (ii) (56.0 mg, 65% yield). IR: ν =
˜
3437 (NH), 1755 (CO2Me), 1651 (C=N) cm–1. 1H NMR: δ = 0.79, trans-(R*,R*)-[PtCl2{NH=C(CH2CO2Me)ON=C(C9H16)}{NH=C-
0.94, and 1.06 (three s, 3 H each, Me groups), 1.21–1.29 (m, 1 H), (CH2CO2Me)N=C(CH2CO2Me)ON=C(C9H16)}] (9a): 46.0 mg,
Eur. J. Inorg. Chem. 2008, 3668–3677
© 2008 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjic.org
3675